Feature Channels:

Pharmaceuticals

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Practical Clinical Trials Can Help Find Alternatives to Opioids

Pressures on primary care doctors to move away from opioid pain management are increasing, but practitioners need practical, evidence-based information on how to employ multidisciplinary pain care successfully in everyday clinical practice. A senior investigator for Kaiser Permanente, speaking at the American Pain Society Annual Scientific Conference, believes wider use of practical clinical trials and more emphasis on patient self-management are key solutions for achieving wider use of multidisciplinary pain care to improve patient function and help lower use and misuse of opioids.

Medicine

Channels:

bladder, Bladder Cancer, bladder cancer clinical trial, pembrolizumab, FDA Approval, FDA approved, FDA Clearance, atezolizumab, chemo side effects, checkpoint inhibitors

Second Drug Receives FDA Approval for Bladder Cancer Based on Research Led by NYU Langone

Balar_Arjun.jpg

The U.S. Food and Drug Administration has granted accelerated approval to a second drug in less than a month for first-line treatment for advanced bladder cancer – again based on clinical trial findings from the same researcher from NYU Langone’s Perlmutter Cancer Center.

Medicine

Channels:

citrin, citrullinemia, Erez, cancer metabolism

Rare Genetic Defect May Lead to Cancer Drug

Dr. Ayelet Erez, a doctor and geneticist at the Weizmann Institute of Science, has found that while a lack of the protein citrin slows children’s growth, blocking it in cancer slows tumor growth

Medicine

Channels:

type 2 diabetes, , Type 2 Diabetes, theurapeutics, Drug Design, anti-diabetic

Designing Better Drugs to Treat Type 2 Diabetes

Research led by the University of Adelaide is paving the way for safer and more effective drugs to treat type 2 diabetes, reducing side effects and the need for insulin injections.

Medicine

Channels:

Non-medical opioid use, young adult, Pain Management, Physical Pain

Pain Linked to Non-Medical Prescription Opioid Use in Young Adults

Physical pain—often "self-medicated" without help from healthcare professionals—is an important contributor to non-medical prescription opioid (NMPO) use by young adults, suggests a study in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine (ASAM). The journal is published by Wolters Kluwer.

Medicine

Channels:

Opiate dependence, Opioid, opioid abuse, Opioid Abuse Epidemic, opioid analgesics, Opioid Addiction, Medical, Medicine, physiciain, Doctor, Medical Regulation, medical board, Guideline

FSMB Releases Updated Guidelines for Chronic Use of Opioid Analgesics

The Federation of State Medical Boards releases its updated guidelines for the chronic use of opioid analgesics.

Medicine

Channels:

Blood Test, Healthcare, Infectious Disease, Healthcare Costs, drug-resistant infections, Public Health

New Blood Test Technology Reduces False Readings, Saves Costs, and Improves Care - Live Virtual Press Briefing with Researcher May 16

Research findings to be published about new blood test technology that will greatly reduce errors in labwork and improve care in public health and infectious disease. Press briefing scheduled for May 16, reserve press access to live virtual event now.

Medicine

Channels:

Blood culture, Contamination, Bacterial Infection, Infectious Disease, Emergency Room, blood sample contamination

Virtual Press Briefing: Novel Device Reduces Blood Sample Contamination, Could Save Billions in Health Care Costs

Newswise hosts a virtual live press briefing on upcoming journal study with research results concerning a new blood collection technique that reduces contamination of blood samples and improves treatment outcomes.

Medicine

Channels:

zika virus, Protease, NS3, NS2B, Inhibitors

New Zika Virus Inhibitor Identified

140794_web.jpg

Compound could serve as basis for drugs to prevent neurological complications of Zika

Medicine

Science

Channels:

Moral Behavior, Moral Enhancement, Technology, Pharmaceticals, Surgery, Neurotechnology, Oxytocin, Amphetamine, SSRI, Beta Blockers, Transcranial Magnetic Stimulation, transcranial direct current stimulation, Deep Brain Stimulation, Research

Study: ‘Moral Enhancement’ Technologies Are Neither Feasible Nor Wise

A recent study finds that “moral enhancement technologies” – which are discussed as ways of improving human behavior – are neither feasible nor wise, based on an assessment of existing research into these technologies.







Chat now!